Carl Icahn
Carl Icahn's Portfolio
| Ticker | # of Shares | Price | Value | |
|---|---|---|---|---|
| CVI | 71,198,718 | $67.84 | $4,830,121,030 | |
| NFLX | 5,541,066 | $236.53 | $1,310,628,341 | |
| CHK | 59,698,689 | $21.08 | $1,258,448,365 | |
| FRX | 30,662,005 | $37.83 | $1,159,943,650 | |
| RIG | 20,154,035 | $53.84 | $1,085,093,245 | |
| HLF | 16,966,485 | $51.25 | $869,532,357 | |
| HLF | 16,355,131 | $51.25 | $838,200,464 | |
| FDML | 76,697,804 | $9.75 | $747,803,589 | |
| NUAN | 33,899,274 | $19.23 | $651,883,040 | |
| HAIN | 7,239,963 | $67.40 | $487,973,507 | |
| View Additional Portfolio Information » | ||||
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
-
American Railcar Industries, Inc. Reports Strong First Quarter 2013
-
It's a Carl Icahn Market
-
Carl Icahn Cuts Stake in Greenbrier Cos. (GBX) to 3.4% Following Failed Bid
-
Stocks Crossing 50-Day SMA 12/21: (AMD) (ABT) (P) Above; (NPSP) (BTU) (GBX) Below
-
Greenbrier (GBX) Again Says Icahn / American Railcar (ARII) Offer Not Enough
-
Greenbrier (GBX) Ticks Lower as Icahn Boosts Offer 10% (ARII)
-
Greenbrier (GBX) Rejects Am. Railcar (ARII) $20/Share Bid
-
Market Wrap: Boehner's 'Other' Plan; Massive Media Measurement Merger; Dick's Halts Rifle Sales
-
Streetinsider.com's Hot Lunchtime Reads 12/18: (DKS) (ARII) (GE) (KBH) (CMG)
-
Icahn-Controlled American Railcar (ARII) Again Takes Aim at Greenbrier (GBX)
-
Notable Mergers and Acquisitions of the Day 12/18: (COP) (NLSN)/(ARB) (GBX) (SLRC) Cerberus
-
UPDATE: Icahn's American Railcar Bids $20/Share for Greenbrier (GBX)
-
Greenbrier (GBX) Comments on Icahn Stake; Says Icahn Suggested Discussions with American Railcar (ARII)
-
Unusual 11 Mid-Day Movers 11/13: (GALE) (ZAZA) (GBX) Higher; (HCLP) (VVTV) (FES) Lower
-
Carl Icahn Files Q3 13F
-
Icahn Boosts Stake in American Railcar (ARII), Maintains Large Yahoo! (YHOO) and Motorola (MOT) Holdings
-
Carl Icahn raises stake in American Railcar Industries (Nasdaq: ARII), Lions Gate (NYSE: LGF) - 13F
-
KeyBanc Upgrades Greenbrier (GBX) to Buy; GBX and ARII Most Likely Candidates for Some Sort of M&A Activity
-
Icahn No Longer Discusing Merger of Greenbrier (GBX) With American Railcar (ARII)
-
Unusual 11 Mid-Day Movers 2/4: SGTL, CHNR, CPSL, GBX, GU Higher; DTG, PPCO, CHRS, CWTR Lower
-
Greenbrier Companies (GBX) Responds To Carl Icahn's 13D
-
Greenbrier (GBX) Soars As Icahn Scoops Up Shares, Recommends Merger With American Railcar (RAIL)
-
Icahn Discloses 9.45% Stake in Greenbrier (GBX), Discusses Possible Combination With American Railcar (ARII)
